Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial.

Alayed Y, Loblaw A, Mendez LC, Correa RJM, Dhar A, Laidley D, Warner A, Fakir H, Wronski M, Conyngham J, Kassam Z, Helou J, D'Souza DP, Velker V, Lock M, Ahmad B, Bauman GS

Open source

DOI: 10.1016/j.radonc.2026.111786
Published: 2026 Sep 15
Container: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.radonc.2026.111786,
  title = {Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial.},
  author = {Alayed Y and Loblaw A and Mendez LC and Correa RJM and Dhar A and Laidley D and Warner A and Fakir H and Wronski M and Conyngham J and Kassam Z and Helou J and D'Souza DP and Velker V and Lock M and Ahmad B and Bauman GS},
  year = {2026},
  journal = {Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  doi = {10.1016/j.radonc.2026.111786},
  url = {https://doi.org/10.1016/j.radonc.2026.111786}
}

RIS

TY  - JOUR
TI  - Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial.
AU  - Alayed Y
AU  - Loblaw A
AU  - Mendez LC
AU  - Correa RJM
AU  - Dhar A
AU  - Laidley D
AU  - Warner A
AU  - Fakir H
AU  - Wronski M
AU  - Conyngham J
AU  - Kassam Z
AU  - Helou J
AU  - D'Souza DP
AU  - Velker V
AU  - Lock M
AU  - Ahmad B
AU  - Bauman GS
PY  - 2026
JO  - Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
DO  - 10.1016/j.radonc.2026.111786
UR  - https://doi.org/10.1016/j.radonc.2026.111786
ER  -

APA

Y, A., A, L., LC, M., RJM, C., A, D., D, L., A, W., H, F., M, W., J, C., Z, K., J, H., DP, D., V, V., M, L., B, A., & GS, B. (2026). Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. https://doi.org/10.1016/j.radonc.2026.111786

Source records

pubmed · retrieved 2026-09-25T20:25:27.395Z